Bioxytran (BIXT) Ownership - Who Owns Bioxytran?
Bioxytran (BIXT) Ownership Overview
- 1.02% Insiders
- 98.98% Public Companies and Individual Investors
The ownership structure of Bioxytran (BIXT) stock is a mix of institutional, retail, and individual investors. , 1.02% is owned by Insiders, and 98.98% is owned by Public Companies and Individual Investors.
The ownership structure of Bioxytran (BIXT) stock is a mix of institutional, retail, and individual investors. , 1.02% is owned by Insiders, and 98.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 17, 2025 | Alan Hoberman | $126,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dale Conaway | 379,177 | Insider | 0.33% | 8,721 |
| Anders Utter | 372,580 | Insider | 0.32% | 8,569 |
| Alan Hoberman | 210,000 | Insider | 0.18% | 4,830 |
| Radka Milanova | 203,688 | Insider | 0.18% | 4,685 |
FAQ
What percentage of Bioxytran (BIXT) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.98% of Bioxytran (BIXT) stock is held by public companies and individual investors.
Who owns the most shares of Bioxytran (BIXT)?
Dale Conaway owns the most shares of Bioxytran (BIXT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
